From the Cardiovascular Research Center, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an 710061 and.
the Advanced Institute for Medical Sciences, Dalian Medical University, Dalian 116044, China
J Biol Chem. 2019 Mar 1;294(9):3284-3293. doi: 10.1074/jbc.RA118.004411. Epub 2018 Dec 20.
Obesity is a major risk for patients with chronic metabolic disorders including type 2 diabetes. Sonic hedgehog (Shh) is a morphogen that regulates the pancreas and adipose tissue formation during embryonic development. Peroxisome proliferator-activated receptor γ (PPARγ) is a member of the nuclear receptor superfamily and one of the most important regulators of insulin action. Here, we evaluated the role and mechanism of Shh signaling in obesity-associated insulin resistance and characterized its effect on PPARγ. We showed that Shh expression was up-regulated in subcutaneous fat from obese mice. In differentiated 3T3-L1 and primary cultured adipocytes from rats, recombinant Shh protein and SAG (an agonist of Shh signaling) activated an extracellular signal-regulated kinase (ERK)-dependent noncanonical pathway and induced PPARγ phosphorylation at serine 112, which decreased PPARγ activity. Meanwhile, Shh signaling degraded PPARγ protein via binding of PPARγ to neural precursor cell-expressed developmentally down-regulated protein 4-1 (NEDD4-1). Furthermore, vismodegib, an inhibitor of Shh signaling, attenuated ERK phosphorylation induced by a high fat diet (HFD) and restored PPARγ protein level, thus ameliorating glucose intolerance and insulin resistance in obese mice. Our finding suggests that Shh in subcutaneous fat decreases PPARγ activity and stability via activation of an ERK-dependent noncanonical pathway, resulting in impaired insulin action. Inhibition of Shh may serve as a potential therapeutic approach to treat obesity-related diabetes.
肥胖是患有 2 型糖尿病等慢性代谢紊乱的患者的主要风险因素。Sonic hedgehog(Shh)是一种形态发生素,可在胚胎发育过程中调节胰腺和脂肪组织的形成。过氧化物酶体增殖物激活受体 γ(PPARγ)是核受体超家族的成员之一,是胰岛素作用的最重要调节剂之一。在这里,我们评估了 Shh 信号在肥胖相关胰岛素抵抗中的作用和机制,并对其对 PPARγ 的作用进行了特征描述。我们发现肥胖小鼠的皮下脂肪中 Shh 表达上调。在分化的 3T3-L1 和大鼠原代培养的脂肪细胞中,重组 Shh 蛋白和 SAG(Shh 信号的激动剂)激活了细胞外信号调节激酶(ERK)依赖性非经典途径,并诱导 PPARγ 在丝氨酸 112 处磷酸化,从而降低了 PPARγ 的活性。同时,Shh 信号通过 PPARγ 与神经前体细胞表达的发育下调蛋白 4-1(NEDD4-1)结合来降解 PPARγ 蛋白。此外,Shh 信号抑制剂维莫德吉(vismodegib)可减弱高脂肪饮食(HFD)诱导的 ERK 磷酸化,并恢复 PPARγ 蛋白水平,从而改善肥胖小鼠的葡萄糖耐量和胰岛素抵抗。我们的发现表明,皮下脂肪中的 Shh 通过激活 ERK 依赖性非经典途径降低了 PPARγ 的活性和稳定性,从而导致胰岛素作用受损。抑制 Shh 可能是治疗肥胖相关糖尿病的一种潜在治疗方法。